Philip Toleikis
Corporate Officer/Principal presso Medway Working Group
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Philip M.
Toleikis is a Member of the Medway Working Group.
He previously worked as the Director & Chief Technology Officer at Sernova Corp.
from 2023 to 2024 and as the VP-Pharmacology, Research & Development at Angiotech Pharmaceuticals, Inc. in 2006.
Dr. Toleikis holds a doctorate degree from the University of British Columbia, a graduate degree from the University of Michigan, and an undergraduate degree from the University of Vermont.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SERNOVA CORP.
1.74% | 25/04/2023 | 5 273 598 ( 1.74% ) | 1 M $ | 31/05/2024 |
Posizioni attive di Philip Toleikis
| Società | Posizione | Inizio |
|---|---|---|
| Medway Working Group | Corporate Officer/Principal | - |
Precedenti posizioni note di Philip Toleikis
| Società | Posizione | Fine |
|---|---|---|
| SERNOVA CORP. | Amministratore Delegato | 05/09/2023 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 |
Formazione di Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
- Borsa valori
- Insiders
- Philip Toleikis
